These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 21554876)

  • 21. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice.
    Zheng B; Lu S; Tong Q; Kong Q; Lou D
    Vaccine; 2013 Sep; 31(41):4578-84. PubMed ID: 23928460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological responses induced by a DNA vaccine expressing RON4 and by immunogenic recombinant protein RON4 failed to protect mice against chronic toxoplasmosis.
    Rashid I; Hedhli D; Moiré N; Pierre J; Debierre-Grockiego F; Dimier-Poisson I; Mévélec MN
    Vaccine; 2011 Nov; 29(48):8838-46. PubMed ID: 21983362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxoplasma gondii immune mapped protein-1 (TgIMP1) is a novel vaccine candidate against toxoplasmosis.
    Cui X; Lei T; Yang D; Hao P; Li B; Liu Q
    Vaccine; 2012 Mar; 30(13):2282-7. PubMed ID: 22310204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice.
    Peng GH; Yuan ZG; Zhou DH; He XH; Liu MM; Yan C; Yin CC; He Y; Lin RQ; Zhu XQ
    Vaccine; 2009 Nov; 27(47):6570-4. PubMed ID: 19720368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice.
    Mévélec MN; Bout D; Desolme B; Marchand H; Magné R; Bruneel O; Buzoni-Gatel D
    Vaccine; 2005 Aug; 23(36):4489-99. PubMed ID: 15935521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study on immuno-effect with GRA4 or SAG2 gene recombinant BCG vaccine of Toxoplasma gondii].
    Li JH; Wu ST; Weng YB; Gan Y; Liu HB; Liu ML; Zhang RL; Gao ST; Huang DN; Geng YJ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun; 25(3):217-21. PubMed ID: 18038782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxoplasma gondii: DNA vaccination with genes encoding antigens MIC2, M2AP, AMA1 and BAG1 and evaluation of their immunogenic potential.
    Dautu G; Munyaka B; Carmen G; Zhang G; Omata Y; Xuenan X; Igarashi M
    Exp Parasitol; 2007 Jul; 116(3):273-82. PubMed ID: 17379212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxoplasma gondii: protective immunity against experimental toxoplasmosis induced by a DNA vaccine encoding the perforin-like protein 1.
    Yan HK; Yuan ZG; Petersen E; Zhang XX; Zhou DH; Liu Q; He Y; Lin RQ; Xu MJ; Chen XL; Zhong XL; Zhu XQ
    Exp Parasitol; 2011 May; 128(1):38-43. PubMed ID: 21310148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effect of vaccination with Toxoplasma lysate antigen and CpG as an adjuvant against Toxoplasma gondii in susceptible C57BL/6 mice.
    El-Malky M; Shaohong L; Kumagai T; Yabu Y; Noureldin MS; Saudy N; Maruyama H; Ohta N
    Microbiol Immunol; 2005; 49(7):639-46. PubMed ID: 16034207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A chloroplast-derived Toxoplasma gondii GRA4 antigen used as an oral vaccine protects against toxoplasmosis in mice.
    Del L Yácono M; Farran I; Becher ML; Sander V; Sánchez VR; Martín V; Veramendi J; Clemente M
    Plant Biotechnol J; 2012 Dec; 10(9):1136-44. PubMed ID: 23020088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of protective Th1 immune responses in mice by vaccination with recombinant Toxoplasma gondii nucleoside triphosphate hydrolase-II.
    Tan F; Hu X; Luo FJ; Pan CW; Chen XG
    Vaccine; 2011 Mar; 29(15):2742-8. PubMed ID: 21315696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene.
    Desolme B; Mévélec MN; Buzoni-Gatel D; Bout D
    Vaccine; 2000 May; 18(23):2512-21. PubMed ID: 10775785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune response induced by recombinant Mycobacterium bovis BCG expressing ROP2 gene of Toxoplasma gondii.
    Wang H; Liu Q; Liu K; Zhong W; Gao S; Jiang L; An N
    Parasitol Int; 2007 Dec; 56(4):263-8. PubMed ID: 17587637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of protective immune response to recombinant Toxoplasma gondii ROP18 antigen by ginsenoside Re.
    Qu D; Han J; Du A
    Exp Parasitol; 2013 Oct; 135(2):234-9. PubMed ID: 23896123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice.
    Chen J; Huang SY; Zhou DH; Li ZY; Petersen E; Song HQ; Zhu XQ
    Vaccine; 2013 Dec; 31(52):6225-31. PubMed ID: 24183979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxoplasma gondii: protective immunity induced by rhoptry protein 9 (TgROP9) against acute toxoplasmosis.
    Chen J; Zhou DH; Li ZY; Petersen E; Huang SY; Song HQ; Zhu XQ
    Exp Parasitol; 2014 Apr; 139():42-8. PubMed ID: 24602875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity and protective efficacy of two recombinant pseudorabies viruses expressing Toxoplasma gondii SAG1 and MIC3 proteins.
    Nie H; Fang R; Xiong BQ; Wang LX; Hu M; Zhou YQ; Zhao JL
    Vet Parasitol; 2011 Sep; 181(2-4):215-21. PubMed ID: 21632181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
    Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
    Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice.
    Vercammen M; Scorza T; Huygen K; De Braekeleer J; Diet R; Jacobs D; Saman E; Verschueren H
    Infect Immun; 2000 Jan; 68(1):38-45. PubMed ID: 10603366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxoplasma gondii protease inhibitor-1 (TgPI-1) is a novel vaccine candidate against toxoplasmosis.
    Cuppari AF; Sanchez V; Ledesma B; Frank FM; Goldman A; Angel SO; Martin V
    Vaccine; 2008 Sep; 26(39):5040-5. PubMed ID: 18675873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.